(FC) Bioquímica y Genética

2022

1. A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma

   Clinical cancer research : an official journal of the American Association for Cancer Research

2. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

   Cancers, Vol. 14, Núm. 1

3. Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence

   Cancers, Vol. 14, Núm. 14

4. Association between ideal cardiovascular health and telomere length in participants older than 55 years old from the SUN cohort

   Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 308-315

5. Association of Prenatal Exposure to Endocrine-Disrupting Chemicals with Liver Injury in Children

   JAMA Network Open, Vol. 5, Núm. 7, pp. E2220176

6. Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma

   Liver International, Vol. 42, Núm. 12, pp. 2855-2870

7. Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

   European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331

8. Bridging the equity gap in patient education: the biliary tract cancer BABEL project

   The Lancet Oncology

9. C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d

   Frontiers in Immunology, Vol. 13

10. Capillary blood, overcoming dinosaur and unicorn stories

    Advances in Laboratory Medicine

11. Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

    Cancers, Vol. 14, Núm. 11

12. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

    Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121

13. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids

    Hepatology, Vol. 76, Núm. 6, pp. 1617-1633

14. Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients

    Haematologica, Vol. 107, Núm. 3, pp. 593-603

15. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 27, pp. 3151-3161

16. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions

    Gut, Vol. 71, Núm. 8, pp. 1669-1683

17. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

18. Comparative Evaluation of Inducible Cre Mouse Models for Fibroblast Targeting in the Healthy and Infarcted Myocardium

    Biomedicines, Vol. 10, Núm. 10

19. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

    Cancer Letters, Vol. 529, pp. 70-84

20. Correction to: Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells (Molecular Medicine, (2011), 17, 11-12, (1374-1382), 10.2119/molmed.2011.00360)

    Molecular Medicine